Clin2
NCT06360133Possibly a fitRecruiting

New eye drop for dry eye disease

Dry Eye

Part of Eyes & vision clinical trials.

This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
700 people
Ages
30 years to 80 years
Study type
Interventional

Who can take part

  • You are 30 to 80 years old.
  • You have dry eye disease in both eyes and have been using artificial tears for at least a month.
  • In the past week, your eye dryness level was 5 out of 10 or higher.
  • A doctor has confirmed your corneas have some damage from dryness (corneal staining score at least 6).
  • Your tear production is low—between 1 and 7 millimeters on a 5-minute Schirmer test.
  • You do not have uncontrolled glaucoma or recent glaucoma surgery.
  • Women who can get pregnant must not be pregnant, nursing, or planning pregnancy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07245017Recruiting· Early Phase 1
Testing JN002 drops for dry eye disease

This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.

Shanghai
NCT07625124Not yet recruiting· Phase 2
Eye drop for dry eye disease

This study tests an experimental eye drop for people with dry eye disease. It aims to see if the drops can reduce symptoms and signs of dry eye.

NCT07740564Recruiting· Phase 3
Study of an eye drop for moderate to severe dry eye

This study tests an investigational eye drop called OT202 to see if it helps people with moderate to severe dry eye. If you join, you'll receive either the study drug or a placebo (no active ingredient) and have your symptoms and eye health monitored for several months.

Bengbu, Anhui
NCT07179055Recruiting· Phase 2
A study of VSJ-110 for dry eye disease

This trial tests a new eye drop called VSJ-110 to see if it is safe and effective for treating dry eye, compared to a placebo (inactive drops). It lasts 8 weeks and may help if you have dry eye symptoms.

Newport Beach, California
NCT06375343Not yet recruiting· Phase 1
New eye drop for dry eye compared to existing solution

This study tests a new eye drop solution (PRO-240) compared to an existing one (Optive) in healthy adults. It aims to see how safe and comfortable the new drops are for dry eye relief.

NCT06985875Not yet recruiting· Phase 3
New eye drop for dry eye relief

This trial tests a new eye drop (0.4% solution) to see if it's safe and effective for people with dry eye. It's for both contact lens wearers and non-wearers who have dry eye symptoms, and aims to find a better way to relieve discomfort.

Hear when a new Dry Eye trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.